AMIOLEX Injection

AMIOLEX Injection is a sterile Amiodarone formulation intended for intravenous infusion in hospital and critical-care settings. Amiodarone is an antiarrhythmic medicine used in the management of serious ventricular rhythm disturbances where rapid clinical intervention and continuous cardiac monitoring may be required. It has an important role in the treatment of recurrent ventricular fibrillation and hemodynamically unstable ventricular tachycardia in appropriately selected patients.

Presented as a 150 mg/3 mL sterile concentrate, AMIOLEX Injection is designed for intravenous infusion under the supervision of qualified healthcare professionals. Its cardiovascular therapeutic profile makes it relevant to critical-care units, cardiac care facilities, emergency departments and hospital-based treatment protocols involving serious cardiac arrhythmias.

Amiodarone influences cardiac electrical activity through multiple electrophysiological mechanisms and helps suppress abnormal ventricular rhythms. Intravenous administration is particularly relevant when acute treatment is required or when oral therapy cannot be used. Because intravenous amiodarone requires appropriate preparation, controlled administration and monitoring, its use is intended for professional healthcare environments.

For pharmaceutical distributors, hospital procurement teams and institutional healthcare suppliers, AMIOLEX Injection represents a specialized cardiovascular injectable within the critical-care portfolio. Its positioning across the injectable, infusion and cardiac therapeutic segments makes it suitable for hospital-focused pharmaceutical requirements.

AMIOLEX Injection should be administered only according to approved prescribing information and under appropriate medical supervision. Patients receiving intravenous amiodarone require suitable cardiovascular monitoring because treatment can be associated with clinically significant effects on blood pressure, heart rate and cardiac conduction.